The Latest

SEARCH BY KEYWORD
BROWSE BY Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Private Circles. Data Ownership, Publication And Monetization

One Sheet
February 8, 2024
RegenMed supports small clinical practices around the world in the design and execution of real-world data and evidence programs. Those programs result in clinically and statistically significant datasets.
IntroductionRegenMed supports small clinical practices around the world in the design and execution of real-world data and evidence programs. Those programs result in clinically and statistically significant datasets. They are the basis of conference presentations, articles, industry support, licensing transactions, and other forms of monetization.Many small provider groups begin by joining Open Access Circles. These cost only $35 per month per subscriber, and $5 per Case (including outcomes capture for two years or more if desired).Open Access Circles are a highly economical way to observe and participate in the full functionality of one or many indication-specific studies. Eventually, however, most small provider groups decide to establish Private Circles.By doing so, they own and control their data. Such ownership and control are the foundation of sustained reputational and financial value for them.‍The Value of Real-World EvidenceReal-world evidence is widely recognized as critical to better clinical decision-making, streamlining regulatory approvals, and supporting marketing claims.RWE is an essential element of the most important trends in healthcare — value-based medicine, health equity, and cost reduction. It is the foundation of many public and private healthcare programs.Private Circles generate datasets which are well-structured, fit-for-purpose and fully validated. They generate valuable real-world evidence.‍Publication and Monetization Through Private CirclesPrivate Circles democratize the ability of clinicians to conduct high-quality and impactful research. They enable ownership of, and control over, the resulting valuable real-world evidence.However, smaller provider groups often do not have the resources or experience necessary to realize the full value of their real-world evidence. RegenMed provides the platforms and processes allowing them to do so.RegenMed works with clinicians to:Enroll regional and international peers into their Private Circles.Generate regular reports for themselves, their patients, regulators and others.Assist with conferences slides and other presentation materials.Help prepare evidence-based posts and newsletters for websites, social media and other channels.Attract funding and other forms of support from industry.In addition, RegenMed can assist Private Circle Founders pursue real-world evidence licensing, intellectual property and other monetization opportunities.‍Getting StartedA Private Circle costs only $500, plus $35 per subscriber month and $5 per Case. A small clinical group can be up and running in a matter of days, with minimal burden.RegenMed works closely and continually with each Private Circle Founder to ensure they obtain the reputational and financial value inherent in their ownership of the resulting real-world evidence.‍Learn MoreWhat Is A CircleHow Circles Work ‍Join/Start A CircleProcesses For Physicians ‍LatestContact UsCopyright © 2024 Regenerative Medicine LLC
See more
Arrow right

Real-World Evidence Featured Prominently at this Year's IOF MAX!

Client News
February 7, 2024
The recent IOF MAX Experience, organized by the Interventional Orthobiologics Foundation, brought together some of the world’s foremost experts on orthobiologics to share their proprietary real-world data and real-world evidence.
Type image caption here (optional)The recent IOF MAX Experience, organized by the Interventional Orthobiologics Foundation, brought together some of the world’s foremost experts on orthobiologics to share their proprietary real-world data and real-world evidence. Many of those experts proudly included a growing number of Circle founders, including: ‍Peter A. Everts, PhD, FRSM opened the show with some nuanced hypotheses for "Where will the Field of Orthobiologics be in 2030?". Those same hypotheses informed his launch of the Gulf Coast Biologics Knee and Shoulder Circles over a year ago.Imran Siddiqui, Research Director at Regenerative Orthopedics & Sports Medicine, presented statistically significant 1 year results from those same Circles. Numerous IOF members joined Dr. Everts and Siddiqui as expert co-investigators, including: Luga Podesta, MD, Glenn M. Flanagan II, Alberto J. Panero D.O., Shounuck Patel, DO, Walter I. Sussman, Gayan Poovendran MD,CAQSM, and Ariana De Mers. Special thanks as well to Dr. Chris Brown Mahoney for her statistical analyses, which is a critical component for elevating real-world "data" into "evidence". Lastly, IOF members and sponsors continue to launch and grow their own real-world studies in 2024. We present their headshots and studies proudly, as their proprietary real-world evidence are bound to play a role in future curriculums, standards and regulatory decisions.Contact us to learn more about Circles.
See more
Arrow right

Circles Monetization Through Generative AI

Post
January 29, 2024
Generative AI (GAI) is considered the most important technical development since the establishment of the Internet. It has profound implications in healthcare. Research, product development, and clinical decision-making are a few major examples.
Generative AI (GAI) is considered the most important technical development since the establishment of the Internet. It has profound implications in healthcare. Research, product development, and clinical decision-making are a few major examples. At the same time, clinical-grade real-world data (RWD) is fast becoming the most important data category in healthcare. More than EMR, payer, RCT, and other types of data, RWD is essential to achieving value-based care, health equity and overall cost reduction in healthcare delivery. GAI/RWD use cases will include value-based care for payers, product development for manufacturers, scientific breakthroughs for researchers, and clinical decision support for providers. Circles represent proprietary and well-structured RWD databases which are ideal for a variety of GAI applications. They possess several important characteristics making them attractive for healthcare-related GAI applications: They are well-structured, enabling the efficient derivation of statistically significant correlations among scientific hypotheses, clinical interventions, and long-term outcomes. They are “fit-for-purpose”. Each Circle database corresponds to one or two well-defined endpoints representing clinically and statistically significant datasets. Data integrity, auditability, scalability, and regulatory compliance. Clear data ownership rights. Ease of integration with other private (e.g., EMR) or public (e.g., open access medical literature) data sources. Circles Founders and Members already capture value from their RWD through publication, study investigator fees, honoraria, and other channels. Their most important opportunity for value creation will likely come from Generative AI. For more information, see our Articles on the importance of real world data and Circles data monetization.
See more
Arrow right
Nothing was found. Please use a single word for precise results.
Stay Informed.
Subscribe for our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.